What if the future of brain tumor treatment is closer than we think?
On this episode of Game On Glio, we sit down with Dr. Annick Desjardins, neuro-oncologist and Director of Clinical Research at Duke’s Preston Robert Tisch Brain Tumor Center, for a powerful conversation about where brain tumor research and treatment are headed—and what that could mean for patients and families facing a diagnosis.
Dr. Desjardins takes us beyond the medical jargon and into the rapidly evolving world of brain tumor care, sharing insight into emerging treatments-including oncolytic and infection driven treatments, and clinical research. We also talk about the importance of hope, innovation, and continuing to push the boundaries of what’s possible when it comes to treating brain tumors.
This is a conversation about science, possibility, and the people at the heart of every breakthrough. Because behind every clinical trial, every new treatment, and every research discovery is a patient waiting for more time, more options—and a reason to believe in what comes next.
Watch on YouTube or listen anywhere you get your podcasts.
If you or a loved is impacted by glioblastoma or other brain cancers and you would like to see if you qualify for a clinical trial, please review the resource list below.
To see clinical trials at Duke brain cancer center, visit: Duke cancer institute trials.
If you like our show, please help us continue to grow and reach new listeners. Share our podcast with others and consider giving us a review on Apple and Spotify! And, please follow us on YouTube.
Season 6 Premier Sponsors:


Watch on YouTube:
Resources from SEASON 6 Ep. 07:
Articles/Blogs:
National Library of Medicine- Role of infectious agents in the carcinogenesis of brain and head and neck cancers
Advanced Science News- Using bacterial infections to help treat brain tumors
Clinical Trials:
CURRENTLY OFFERING! CeGaT- CegaT Cancer NEO
CURRENTLY RECRUITING! Lenox Hill/Northwell Health- Tissue autograf to bypass the blood brain barrier (BBB) in human glioblastoma multiforme,
CURRENTLY RECRUITING! Duke Brain Tumor Center- Oncolytic HSV1 MVR-C5252 in Patients with rHGG (Recurrent Glioma)
New FDA Approved Pediatric Brain Cancer Drug! Jazz Pharmaceuticals- Modeyso for treatment of mutant Diffuse Midline Glioma
CURRENTLY RECRUITING! Alpheus Medical – Ultrasound therapy for glioblastoma
CURRENTLY RECRUITING! Duke Brain Cancer Institute – D2C7-IT/2141-V11 for Newly diagnosed GBM
CURRENTLY RECRUITING! Lenox Hill Brain Tumor Center – Azeliragon in MGMT Unmethylated Glioblastoma
Books:

For more resources, visit our resource page here.
Hosted by Shannon Traphagen


Be First to Comment